Treatment with biologic DMARDs vs standard therapy improved clinical response rates and flare outcomes among patients with polyarticular JIA.

Dr. Beth Jonas answers the question: 'Newer Vs. Older DMARDs for Rheumatoid?' — -- Question: How do the older DMARDs differ from the newer DMARDs and is either group of drugs better for the ...

DMARDs, including TNF-alpha inhibitors, may relieve pain and inflammation and help prevent joint damage from rheumatoid arthritis (RA). TNF-alpha inhibitors block TNF-alpha, which causes joint pain ...

Dr. Beth Jonas answers the question: 'DMARDs For Rheumatoid Arthritis Pain?' — -- Question: What are disease-modifying antirheumatic drugs (DMARDs) and how are they used to treat rheumatoid ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

A study conducted in Denmark showed that treatment of rheumatoid arthritis with disease modifying antirheumatic drugs (DMARDs), glucocorticoids, biologic agents, or a combination of agents ...

Please provide your email address to receive an email when new articles are posted on . Biologic disease-modifying antirheumatic drugs used to treat juvenile rheumatic diseases are excluded entirely ...

rheumatoid arthritis dmard vs biologic Updated American College of Rheumatology recommendations suggest using first-line DMARDs in combination with biologic agents and nonbiologic DMARDs to achieve ...

Biologic vs conventional DMARDs may offer cardioprotective benefits among patients with PsA, though an increased risk for infection requires vigilance.

While overall risks for adverse birth outcomes were not increased in children born to fathers who used disease-modifying antirheumatic drugs (DMARDs), such as methotrexate, for autoimmune diseases in ...

Please provide your email address to receive an email when new articles are posted on . Among patients with rheumatoid arthritis, observed rates of major adverse events from biologic/targeted ...